Dirk Westermann

Cardiologist. All tweets are personal opinion and no medical advice. Grateful to work at UHZ Freiburg / Bad Krozingen @UHZ_UNIFreiburg

[Davide Capodanno @DFCapodanno]

https://t.co/vRC1tZMRjp

[Alexander Maier @alexm_lab]

a snapshot from our recent #BASILICA case of a native aortic valve @UHZ_UNIFreiburg @dirkwestermann @HilgendorfIngo @PCRonline #TAVI #echofirst

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Femoral or Radial Secondary Access in TAVR: A Subanalysis From the Multicenter PULSE Registry: @JACCJournals

🥸So we tried to use #radialfirst in TAVR like the old days, but we were shot by anesthesia!

😱Summary

👇👇👇

[Philipp Breitbart @Kardiophil]

Out now - our latest Editorial
"Machine learning paving the way for successful antegrade crossing of total chronic coronary occlusions"

https://t.co/ogSYFKpUtT
@gkorosoglou @dirkwestermann @Herzmedizin_de
@AGIKinterv
@esbrilakis

[Christian Gratzke @cgratzke]

Merry Xmas! The team of Urology, @uni-freiburg.de, would like to thank all our co-workers and cooperation partners for the support in 2024. And to all patients: please go see a Urologist if needed! We are here for you…

[TIMI Study Group @TIMIStudyGroup]

"#HscTnI is a known marker of CV risk, but what about changes 🔃 over time? New study by @PaulMHaller and @marstonMD using >20k pts from FOURIER trial explores how serial increases & decreases in hs-cTnI reflect shifts⤴️/⤵️ in risk of major CV event risk. #CardioTwitter #AHA24"

[Vas Panoulas @VPanoulas]

Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock: A Substudy of the DanGer Shock Randomized Clinical Trial | Critical Care Medicine | JAMA Cardiology | JAMA Network - lmpella patients need less inotropes… https://t.co/rNovaSa6We

[Davide Capodanno @DFCapodanno]

Ouch, QFR. In the FAVOR III Europe trial, it loses out against FFR for PCI guidance. For those who enjoy statistical tortures, QFR didn’t just fail to show noninferiority; it was actually inferior. More stents, more myocardial infarctions. Who will give me back the hours I spent obtaining the certification? #TCT2024 https://t.co/tq8cOVf6MF

[Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA @ShashankSinhaMD]

How should we apply #DanGer #Shock results in U.S.? #DrDavidMorrow shares insights #Patient selection 🔑 ⁦@CCCTNetwork⁩ ⁦@TIMIStudyGroup⁩ ⁦@JasonKatzMD⁩ ⁦@seanvandiepen⁩ ⁦@ddbergMD⁩ ⁦@EBohula⁩ ⁦@ankeetbhatt⁩ ⁦@TCTConference⁩ #TCT24

[Babar Basir @Babar_Basir]

Always the biggest most exciting meeting of the year #TCT2024 Check out an amazing session on CS & MCS led by @alaide_chief & @dirkwestermann at 10:30, including 3 analyses from Danger Shock @LHolmvang @djc795 & the first look into the future of small bore MCS @DrAmirKaki

[Circulation Research @CircRes]

5/5 Chronic Activation of Tubulin Tyrosination in HCM Mice and in Human iPSC-Engineered Heart Tissues Improves Heart Function by Pietsch et al https://t.co/R6jMnJqh8O
@Prosser_Lab @mcaporizzo @CyxChristina @dirkwestermann @LucasBacmeister

[Philipp Breitbart @Kardiophil]

Wie Samstagnachmittag in Länderspielpause verbringen?
Manuskript zu unserer Studie zum Vergleich der Verletzungscharakteristika zwischen 1. & 2. Bundesliga schreiben⚽️
@UHZ_UNIFreiburg @DFL_Official @Hannah_Billig_ @CMoffiziell @Marv2punkt0 @jongichun @basti_red @dirkwestermann

[Philipp Breitbart @Kardiophil]

Volles Haus beim #UHZWissenschaftstag auf Initiative von @HilgendorfIngo @dirkwestermann
Viele junge engagierte Talente stellen spannende Projekte ihrer AGs am UHZ vor.
💪 Tolle Werbung für eine klinische und wissenschaftliche Laufbahn am @UHZ_UNIFreiburg

@YoungDgk
@DGK_org

[Ingo Hilgendorf @HilgendorfIngo]

@Kardiophil @dirkwestermann @UHZ_UNIFreiburg @YoungDgk @DGK_org Und jetzt Poster Session mit Imbiss

[Jaffar Khan @CathElectroSurg]

A long journey. Thank you to all collaborators, co-inventors, co-authors, co-pioneers!

Here are the complete 5-year data for the NHLBI LAMPOON trial.

[Dirk Westermann @dirkwestermann]

@g_giustinoMD @AtlanticHealth Great case and really cool videos. But what are the advantages over LAMPOON?

[Jaffar Khan @CathElectroSurg]

Thank you and looking forward to it!

[TIMI Study Group @TIMIStudyGroup]

In 32,000 AF pts from COMBINE-AF, cardiac #biomarkers sign.⤴️ #heartfailure risk prediction! hs-cTnT as important as NTproBNP pointing to a promising dual-marker strategy. Results simultaneously published in @JACCJournals @PaulMHaller @rgiugliano #ESCCongress

[Holger Thiele @thiele_holger]

#ESCCongress just out now: IPD metaanalysis of all RCTs MCS vs control. Published now ⁦@TheLancet⁩ ⁦@CHassager⁩ ⁦@PCSchulzeMD⁩ ⁦@AnneFreund3⁩ ⁦@JaninePoss⁩ ⁦@AGIKinterv⁩ ⁦@DGK_org⁩ ⁦@Herzmedizin_de⁩ ⁦⁦@dzhk_germany⁩

[Geoffrey Christanday @TenX_Life]

Congratulations to @thiele_holger on the recently published independent patient data meta-analysis evaluating whether VA ECMO benefit DanGer-like patients.

https://t.co/aQdo8a1r3x